Holen Sie sich die Stockscreener-App
0.3841
0.23%
-0.0009
Vorhandelsmarkt:
.38
-0.0041
-1.07%
Schlusskurs vom Vortag:
$0.385
Offen:
$0.371
24-Stunden-Volumen:
113.60K
Relative Volume:
0.59
Marktkapitalisierung:
$15.15M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.67M
KGV:
-0.1243
EPS:
-3.09
Netto-Cashflow:
$-101.06M
1W Leistung:
-0.75%
1M Leistung:
-2.02%
6M Leistung:
+12.47%
1J Leistung:
-22.34%
1-Tages-Spanne:
$0.371
$0.39
1-Wochen-Bereich:
$0.3626
$0.40
52-Wochen-Spanne:
$0.2195
$0.8264
Athira Pharma Inc Stock (ATHA) Company Profile
Firmenname
Athira Pharma Inc
Sektor
Branche
Telefon
(425) 620-8501
Adresse
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL
Vergleichen Sie ATHA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATHA
Athira Pharma Inc
|
0.3841 | 15.18M | 0 | -117.67M | -101.06M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.48 | 101.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
482.13 | 59.64B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.53 | 59.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
767.00 | 47.00B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
351.13 | 38.12B | 3.81B | -644.79M | -669.77M | -6.24 |
Athira Pharma Inc Stock (ATHA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-19 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-09-04 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-09-04 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-09-04 | Herabstufung | Rodman & Renshaw | Buy → Neutral |
| 2024-08-19 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-10-17 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-06-23 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-06-23 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-23 | Herabstufung | Stifel | Buy → Hold |
| 2022-05-10 | Eingeleitet | BTIG Research | Buy |
| 2022-04-21 | Eingeleitet | Berenberg | Buy |
| 2021-12-15 | Eingeleitet | Goldman | Neutral |
| 2020-10-13 | Eingeleitet | Goldman | Buy |
| 2020-10-13 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-10-13 | Eingeleitet | Jefferies | Buy |
| 2020-10-13 | Eingeleitet | Stifel | Buy |
Alle ansehen
Athira Pharma Inc Aktie (ATHA) Neueste Nachrichten
Is Athira Pharma Inc. stock reversal real or fake2025 Pullback Review & AI Driven Stock Reports - Newser
Analyzing net buyer seller activity in Athira Pharma IncJuly 2025 Sector Moves & Breakout Confirmation Alerts - Newser
What MACD and RSI say about Athira Pharma Inc.July 2025 Rallies & Verified Momentum Stock Ideas - Newser
What’s the recovery path for long term holders of Athira Pharma Inc.July 2025 Sector Moves & Short-Term Swing Trade Alerts - Newser
Applying Wyckoff theory to Athira Pharma Inc. stockJuly 2025 Fed Impact & High Yield Stock Recommendations - Newser
Using data models to predict Athira Pharma Inc. stock movementJuly 2025 Volume & High Accuracy Swing Entry Alerts - Newser
Using AI based signals to follow Athira Pharma Inc.July 2025 Outlook & Stock Portfolio Risk Management - Newser
Is Athira Pharma Inc. stock bottoming outJuly 2025 Intraday Action & Short-Term Trading Alerts - Newser
What does recent volatility data suggest for Athira Pharma Inc.2025 Bull vs Bear & Safe Swing Trade Setups - Newser
Chart based analysis of Athira Pharma Inc. trendsJuly 2025 Volume & Weekly Market Pulse Alerts - Newser
Using economic indicators to assess Athira Pharma Inc. potentialJuly 2025 Intraday Action & Free AI Powered Buy and Sell Recommendations - Newser
Has Athira Pharma Inc. found a price floorMarket Growth Report & Technical Analysis for Trade Confirmation - Newser
Smart tools for monitoring Athira Pharma Inc.’s price actionJuly 2025 Price Swings & Expert Curated Trade Setups - Newser
What to expect from Athira Pharma Inc. in the next 30 days2025 Price Targets & AI Forecast Swing Trade Picks - Newser
Price momentum metrics for Athira Pharma Inc. explainedJuly 2025 Retail & Short-Term Trading Alerts - Newser
Relative strength of Athira Pharma Inc. in sector analysisBreakout Watch & Low Risk High Win Rate Picks - Newser
applying wyckoff theory to athira pharma inc. stockQuarterly Trade Report & Breakout Confirmation Alerts - Newser
Is it too late to sell Athira Pharma Inc.Weekly Gains Summary & Risk Adjusted Swing Trade Ideas - Newser
What Fibonacci levels say about Athira Pharma Inc. rebound2025 EndofYear Setup & AI Driven Stock Movement Reports - Newser
Will Athira Pharma Inc. benefit from macro trendsWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - Newser
What moving averages say about Athira Pharma Inc.Earnings Beat & Risk Controlled Stock Alerts - Newser
Exit strategy if you’re trapped in Athira Pharma Inc.July 2025 Earnings & Consistent Growth Equity Picks - Newser
Applying Elliott Wave Theory to Athira Pharma Inc.Quarterly Market Summary & Real-Time Volume Analysis Alerts - Newser
Using fundamentals and technicals on Athira Pharma Inc.Short Setup & Real-Time Market Trend Scan - Newser
Volume Surge May Signal Institutional Interest in Athira Pharma Inc.Market Trend Report & AI Driven Price Predictions - beatles.ru
What data driven models say about Athira Pharma Inc.’s futureBull Run & Technical Pattern Recognition Alerts - Newser
Does Athira Pharma Inc. show high probability of reboundJuly 2025 Trends & Community Verified Trade Signals - Newser
How to read the order book for Athira Pharma Inc.2025 Key Lessons & Capital Efficiency Focused Strategies - Newser
Can volume confirm reversal in Athira Pharma Inc.Trade Risk Assessment & Weekly Stock Performance Updates - Newser
Is Athira Pharma Inc. a candidate for recovery play2025 Fundamental Recap & Accurate Trade Setup Notifications - Newser
Is Athira Pharma Inc. stock risky to hold nowDollar Strength & Stock Timing and Entry Methods - beatles.ru
Live market analysis of Athira Pharma Inc.Market Trend Report & Growth Focused Entry Reports - Newser
What to do if you’re stuck in Athira Pharma Inc.Dividend Hike & Proven Capital Preservation Tips - Newser
Is Athira Pharma Inc. exposed to political riskInsider Selling & Low Drawdown Investment Strategies - 시사인 투데이
Finanzdaten der Athira Pharma Inc-Aktie (ATHA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.96%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):